RAPT Therapeutics, Inc(NASDAQ:RAPT) 
RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead oncology drug candidate is FLX475, an oral small m...
Website: http://www.flxbio.com
Founded: 2015
Full Time Employees: 71
CEO: Brian Russell Wong
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 8.88
H 8.88
L 8.32
C 8.48
V 483,573
10EMA 8.48
20EMA 8.48
60EMA 8.48
120EMA 8.48
250EMA 8.48